Cargando…

Severity of Cardiovascular Disease Outcomes Among Patients With HIV Is Related to Markers of Inflammation and Coagulation

BACKGROUND: In the general population, raised levels of inflammatory markers are stronger predictors of fatal than nonfatal cardiovascular disease (CVD) events. People with HIV have elevated levels of interleukin‐6 (IL‐6), high‐sensitivity C‐reactive protein (hsCRP), and D‐dimer; HIV‐induced activat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nordell, Anna D., McKenna, Matthew, Borges, Álvaro H., Duprez, Daniel, Neuhaus, Jacqueline, Neaton, James D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 2014
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4309077/ https://www.ncbi.nlm.nih.gov/pubmed/24870935 http://dx.doi.org/10.1161/JAHA.114.000844

Ejemplares similares

Inflammation, Coagulation and Cardiovascular Disease in HIV-Infected Individuals
por: Duprez, Daniel A., et al.
Publicado: (2012)

HIV Replication Alters the Composition of Extrinsic Pathway Coagulation Factors and Increases Thrombin Generation
por: Baker, Jason V., et al.
Publicado: (2013)

Inflammatory and Coagulation Biomarkers and Mortality in Patients with HIV Infection
por: Kuller, Lewis H, et al.
Publicado: (2008)

Pre-ART Levels of Inflammation and Coagulation Markers Are Strong Predictors of Death in a South African Cohort with Advanced HIV Disease
por: Ledwaba, Lotty, et al.
Publicado: (2012)

E-Selectin and markers of HIV disease severity, inflammation and coagulation in HIV-infected treatment-naïve individuals
por: Hoffman, Madelein, et al.
Publicado: (2018)

Systemic Inflammation, Coagulation, and Clinical Risk in the START Trial
por: Baker, Jason V, et al.
Publicado: (2017)

Markers of Inflammation and Infection in Sepsis and Disseminated Intravascular Coagulation
por: Patel, Priya, et al.
Publicado: (2019)

The Interface between Inflammation and Coagulation in Cardiovascular Disease
por: Demetz, Gabriele, et al.
Publicado: (2012)

Management of coagulation disorders in severe inflammation
por: Lassila, Riitta, et al.
Publicado: (2019)

Derivation of a Protein Risk Score for Cardiovascular Disease Among a Multiracial and Multiethnic HIV+ Cohort
por: Safo, Sandra E., et al.
Publicado: (2023)

Activation of Markers of Inflammation, Coagulation and Fibrinolysis in Musculoskeletal Trauma
por: Reikerås, Olav, et al.
Publicado: (2014)

When to start antiretroviral therapy: the need for an evidence base during early HIV infection
por: Lundgren, Jens D, et al.
Publicado: (2013)

In silico thrombin generation: Plasma composition imbalance and mortality in human immunodeficiency virus
por: Brummel‐Ziedins, Kathleen E., et al.
Publicado: (2018)

Peptidoglycan and Bacterial DNA Induce Inflammation and Coagulation Markers in Synergy
por: Amoureux, Marie-Claude, et al.
Publicado: (2005)

Protease inhibitors and cardiac autonomic function in HIV-infected patients: a cross-sectional analysis from the Strategies for Management of Antiretroviral Therapy (SMART) Trial
por: Soliman, Elsayed Z, et al.
Publicado: (2013)

Role of T‐Cell Dysfunction, Inflammation, and Coagulation in Microvascular Disease in HIV
por: Sinha, Arjun, et al.
Publicado: (2016)

Markers of coagulation dysfunction and inflammation in diabetic and non-diabetic COVID-19
por: Varikasuvu, Seshadri Reddy, et al.
Publicado: (2020)

Adjudicated Morbidity and Mortality Outcomes by Age among Individuals with HIV Infection on Suppressive Antiretroviral Therapy
por: Miller, Christopher J., et al.
Publicado: (2014)

Contact pathway of coagulation and inflammation
por: Wu, Yi
Publicado: (2015)

Inflammation, infection and coagulation disorders
por: Sandset, Per Morten
Publicado: (2019)

Sleep Irregularity and Subclinical Markers of Cardiovascular Disease: The Multi‐Ethnic Study of Atherosclerosis
por: Full, Kelsie M., et al.
Publicado: (2023)

Markers of inflammation and coagulation indicate a prothrombotic state in HIV-infected patients with long-term use of antiretroviral therapy with or without abacavir
por: Jong, Eefje, et al.
Publicado: (2010)

Association of Suboptimal Antiretroviral Therapy Adherence With Inflammation in Virologically Suppressed Individuals Enrolled in the SMART Study
por: Castillo-Mancilla, Jose R, et al.
Publicado: (2017)

Tocilizumab for severe COVID-19: A promising intervention affecting inflammation and coagulation
por: Levi, Marcel
Publicado: (2020)

Tourniquet-Applied Upper Limb Orthopaedic Surgery Results in Increased Inflammation and Changes to Leukocyte, Coagulation and Endothelial Markers
por: Hughes, Stephen F., et al.
Publicado: (2010)

Angiotensin Converting Enzyme Inhibitor and HMG-CoA Reductase Inhibitor as Adjunct Treatment for Persons with HIV Infection: A Feasibility Randomized Trial
por: Baker, Jason V., et al.
Publicado: (2012)

Cardiovascular markers of inflammation and serum lipid levels in HIV-infected patients with undetectable viraemia
por: Viskovic, Klaudija, et al.
Publicado: (2014)

Cardiovascular markers of inflammation and serum lipid levels in HIV-infected patients with undetectable viremia
por: Višković, Klaudija, et al.
Publicado: (2018)

Insomnia symptoms and biomarkers of monocyte activation, systemic inflammation, and coagulation in HIV: Veterans Aging Cohort Study
por: Polanka, Brittanny M., et al.
Publicado: (2021)

An exploratory study of the effects of strenuous exercise on markers of coagulation activation, circulating microparticles, and inflammation in sickle cell trait
por: Skinner, Sarah, et al.
Publicado: (2020)

In-Traffic Air Pollution Exposure and CC16, Blood Coagulation, and Inflammation Markers in Healthy Adults
por: Zuurbier, Moniek, et al.
Publicado: (2011)

Ovarian cancer, the coagulation pathway, and inflammation
por: Wang, Xipeng, et al.
Publicado: (2005)

Endothelium—role in regulation of coagulation and inflammation
por: van Hinsbergh, Victor W. M.
Publicado: (2011)

Changes in coagulation markers in children with Mycoplasma pneumoniae pneumonia and their predictive value for Mycoplasma severity
por: Li, Yong-tao, et al.
Publicado: (2023)

Circulating Histone Levels Correlate with the Severity of COVID-19 and the Extent of Coagulation Activation and Inflammation
por: Shaw, Rebecca Jane, et al.
Publicado: (2020)

Cirrhosis-Associated RAS-Inflammation-Coagulation Axis Anomalies: Parallels to Severe COVID-19
por: Hartl, Lukas, et al.
Publicado: (2021)

Abnormal Coagulation Function of Patients With COVID-19 Is Significantly Related to Hypocalcemia and Severe Inflammation
por: Qi, Xu, et al.
Publicado: (2021)

Association of Soluble Markers of Inflammation With Peri-coronary Artery Inflammation in People With and Without HIV Infection and Without Cardiovascular Disease
por: Freeman, Michael L, et al.
Publicado: (2023)

The relationship between cardiac injury, inflammation and coagulation in predicting COVID-19 outcome
por: Mengozzi, Alessandro, et al.
Publicado: (2021)

The short- and long-term associations of particulate matter with inflammation and blood coagulation markers: A meta-analysis()
por: Tang, Hong, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_cqcp36ibht2divjga1i0rg39th